Human papillomavirus vaccine 2021

Concepts

• vaccines
• provision of human papillomavirus vaccine
• human papillomavirus vaccine
• sensitive information
• legitimate commercial interest of the supplier
• april
• march

Location

United Kingdom: Bedford, UK

Description

The provision of human papillomavirus vaccine

Total Quantity or Scope

The provision of human papillomavirus vaccine, deliveries will berequired from 1 April 2021 to 31 March 2025. Additional information: Value — this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier

Award Detail

Award Criteria

CPV Codes

• 33651600 - Vaccines

Legal Justification

There is only one supplier with an exclusive global licence to manufacture and distribute this vaccine which is licensed and approved for use in the UK and due to the functions of thevaccine, there is no reasonable alternative or substitute, therefore using the negotiated procedure without prior publication is justified under Regulation 32(2)(b)(ii) and (iii) of thePublic Contracts Regulations 2015

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The contract(s) is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective vaccination programmes.